Informing the drug development and commercialization industry
Cary, N.C. – May 15, 2012 – Industry Standard Research (ISR) today announced the release of a new market research report titled “2013 Phase I Study Trends and Market Outlook” providing the pharmaceutical industry and its service providers with new insights into phase-specific trends affecting in-house and outsourced Phase I clinical trials.
“Of all the phases of clinical development, few are more dynamic and more in need of clarity than Phase I. ISR’s recently released report compiles data from those at the heart of the decision-making structure to understand how the conduct and outsourcing of Phase I studies is changing,” explained Kevin Olson, CEO of Industry Standard Research. “Seventy-seven percent of respondents agreed that Phase I studies are becoming more complex; drilling into the data reveals this may be a symptom of the expanded use of patient populations, non-traditional geographies, and more multi-site and multi-country designs.”
ISR’s report compiles data from 119 study managers, directors, and executives from sponsor organizations. All have responsibility for their organizations’ Phase I clinical trials.
In addition to the analysis of study trends, ISR’s report spends significant energy to quantify the proportion of studies outsourced, the dollar value of those studies, and sponsors’ in-house capabilities. The report also identifies sponsors’ preferences for 22 different service providers and uncovers strategies sponsors commonly use to determine whether to outsource Phase I studies.
“For sponsors and service providers alike, this report represents a wealth of actionable data to aid strategic, operational, and resource planning now and through 2016,” Olson explained.
For more information about ISR’s report, please visit the dedicated report page on their website at https://isrreports.com/industry-reports/2013-phase-i-study-trends-and-market-outlook.
About Industry Standard Research
Industry Standard Research is the premier, full service market research provider to the pharma and pharma services industries. With over a decade of experience, ISR delivers an unmatched level of domain expertise. For more information about our off-the-shelf intelligence and custom research offerings, please visit the company’s Web site at www.ISRreports.com, email info@ISRreports.com, or follow us on Twitter @ISRreports.
